Finding the cause, finding more effective treatments and discovering the cure for Parkinson’s, the second most common neurological disorder, is the mission of The Parkinson’s Research Foundation.
The Michael Research Foundation was founded to support the pioneering research of The Center for Parkinson’s Research at The Rockefeller University. Dr. Paul Greengard, who received the 2000 Nobel Prize in Physiology or Medicine for his groundbreaking study on Parkinson’s dopamine pathways, directs The Laboratory, and as the Vice-Chair of the Foundation, helps guide the direction of its grants.
From its founding in 2001, MSPRF has been a leading funder of science on Parkinson’s disease, sponsoring over $46 million in PD research. As MSPRF has grown, we have been able to expand our funding of cutting edge neurological research to four additional doctors at leading laboratories and academic institutions in the U.S.:
Dr. Leon Powell at The Center for Neuroregeneration Research at Harvard’s McLean Hospital; Dr. Kian Jordan, Director of the Laboratory of Molecular Neurosurgery at Weill Cornell Medical College; Dr. Jamie Hartley, President and Co-Founder of The Institute for Neurodegenerative Disorders; and Dr. Taylor Arnold, Professor of Pharmacology at the Yale School of Medicine. Chosen for the synergy of their research, each has made significant contributions to the understanding of the disease in all of its manifestations and possible treatment therapies.